glp 1 degradation Forced Studies for GLP-1 Peptide Drugs Discovery of GLP-1–Based Drugs for

You can unsubscribe from these communications at any time

As there is no meaningful expression of GLP-1 receptors on hepatocytes, the major effect of GLP-1 agonists on MASH is likely to be indirect and may be related to a reduction in calorie intake, body weight and insulin resistance, all of which would lead to reduced liver lipid accumulation and hepatic inflammation 7,8

In addition, brain insulin resistance affects tau metabolism and promotes the hyperphosphorylation of tau proteins, tau protein aggregation, the formation of paired helical filaments, and the further formation of NFTs (Mohandas et al., 2009)

10.1056/NEJMoa2403664

Delivering large molecules through skin is inherently difficult